Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.39 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.39 |
| ▸ | ITGAL | P20701 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5255790 | 0.90 | CES2 (0.43) | RIPK1ITGB2ICAM1ITGALKDM4E | |
| SCHEMBL7683035 | 0.88 | CES2 (0.44) | ITGB2ICAM1ITGALCES2CES1 | |
| SCHEMBL2836425 | 0.80 | KMT2A (0.47) | KDM4EGAAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL5251229 | 0.80 | KMT2A (0.50) | KDM4EGAAALDH1A1HPGDL3MBTL1 | |
| SCHEMBL11139560 | 0.79 | CXCL8 (0.45) | RIPK1ITGB2ICAM1ITGALKDM4E | |
| SCHEMBL28852475 | 0.79 | CES2 (0.41) | RIPK1ITGB2ICAM1ITGALKDM4E | |
| SCHEMBL14491194 | 0.78 | ALDH1A1 (0.43) | MAPK1KDM4ECES2CES1GAA | |
| SCHEMBL7676477 | 0.78 | AKR1C3 (0.41) | CES2CES1 | |
| SCHEMBL23301921 | 0.77 | CES2 (0.50) | MAPK1RIPK1ITGB2ICAM1ITGAL | |
| SCHEMBL29723941 | 0.77 | CES2 (0.50) | MAPK1RIPK1ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1431299-B1 | IMIDAZO(1,2-a)PYRIMIDINES AND FUNGICIDE COMPOSITIONS CONTAINING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2007-05-23 | — | — | EP | disclosed |
| US-7211545-B2 | Imidazo[1,2-a]pyrimidine and fungicidal compositions containing thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-01 | — | — | US | disclosed |
| US-20040235865-A1 | Imidazo[1,2-a]pyrimidine and fungicidal compositions containing thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-11-25 | — | — | US | disclosed |
| EP-1431299-A1 | IMIDAZO(1,2-a)PYRIMIDINES AND FUNGICIDE COMPOSITIONS CONTAINING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2004-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235865-A1 | Imidazo[1,2-a]pyrimidine and fungicidal compositions containing thereof | CBR1, NAT1, CBR3 | MAPK1 2051/4885RIPK1 2971/4885ITGB2 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.